Pfizer Inc. et al v. Viwit Pharmaceutical Co., Ltd.
| Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and Pfizer Products Inc. |
| Viwit Pharmaceutical Co., Ltd. |
| 1:2020cv00160 |
| January 31, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 21, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 STIPULATION and [Proposed] Order Setting Deadline for Defendant to Answer or Otherwise Respond to Complaint re #1 Complaint, by Viwit Pharmaceutical Co., Ltd.. (Townsend, Ethan) |
SO ORDERED, re #7 Stipulation filed by Viwit Pharmaceutical Co., Ltd., Set/Reset Answer Deadlines: Viwit Pharmaceutical Co., Ltd. answer due 5/25/2020. Signed by Judge Colm F. Connolly on 2/21/2020. (fms)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 AFFIDAVIT of Service for Summons, Complaint and related papers served on Viwit Pharmaceutical Co., Ltd. on February 4, 2020, filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer Products Inc.. (Smith, Rodger) |
| Summons Issued with Magistrate Consent Notice attached as to Viwit Pharmaceutical Co., Ltd. on 2/3/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Products Inc. filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer Products Inc. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,410,550 B1 ;6,890,927 B2 ;7,265,119 B2. (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 20, 2019. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 6/20/2022. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Viwit Pharmaceutical Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2841608.) - filed by Pfizer Products Inc., Pfizer Inc., PF Prism C.V., C.P. Pharmaceuticals International C.V. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
